Equashield, a leading provider of Closed System Transfer Devices (CSTD) for safe and simple handling of hazardous drugs, announced today that it is expanding its range of solutions and products ...

The MarketWatch News Department was not involved in the creation of this content. PORT WASHINGTON, N.Y., Dec. 3, 2025 /PRNewswire/ -- EQUASHIELD(R) , a global leader in Closed System Transfer Devices ...

PORT WASHINGTON, N.Y., May 22, 2025 /PRNewswire/ -- EQUASHIELD ®, a global leader in Closed System Transfer Devices (CSTDs) and automated compounding solutions, proudly announces that it has been ...

Equashield Remains the Provider of Choice and Most Considered Closed System Transfer Device for Pharmacists and Oncology Nurses in Prevention of Hazardous Drug Exposure A growing number of facilities ...

The recent clearance reconfirms the freedom to utilize the entire volume of EQUASHIELD's Syringe Unit, leading to enhanced cost savings and safety with handling of hazardous drugs. PORT WASHINGTON, ...

Equashield is the first to introduce CSTDs to Romania, helping protect healthcare workers in light of increased demand for chemotherapy drugs PORT WASHINGTON, New ...

The deal puts Equashield at a valuation of $300 million Equashield was founded in 2009 Since inception in 1989, Nordic Capital has invested more than 20 billion euros in equity capital in over 125 ...

PORT WASHINGTON, N.Y., Dec. 3, 2025 /PRNewswire/ -- EQUASHIELD ®, a global leader in Closed System Transfer Devices (CSTD) and pharmacy automation, will highlight its fully integrated hazardous drug ...